Home / MissionIR Articles

MissionIR Articles

  • OvaScience (OVAS) Presents at Rodman & Renshaw Conference

    OvaScience, Inc. (NASDAQ: OVAS) is a global life sciences company dedicated to improving fertility for women around the world. OvaScience is discovering, developing and commercializing new fertility treatments because it believes women deserve more options.…

  • Orient Paper (ONP) Presents at Rodman & Renshaw Conference

    Orient Paper, Inc. (NYSE: ONP) is a leading paper manufacturer in North China. Using recycled paper as its primary raw material (with the exception of its digital photo paper and tissue paper products), Orient Paper produces…

  • Oramed Pharmaceuticals (ORMP) Presents at Rodman & Renshaw Conference

    Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP) was established in 2006, and has developed a unique proprietary platform technology that allows for the oral delivery of drugs presently administered only via injection. From the company’s inception, Oramed…

  • Opexa Therapeutics (OPXA) Presents at Rodman & Renshaw Conference

    Opexa Therapeutics, Inc. (NASDAQ: OPXA) is a biotechnology company developing personalized immunotherapies with the potential to treat major illnesses, including multiple sclerosis (MS) as well as other autoimmune diseases, such as neuromyelitisoptica (NMO). These therapies…

  • Oncothyreon (ONTY) Presents at Rodman & Renshaw Conference

    Oncothyreon, Inc. (NASDAQ: ONTY) is a biotechnology company dedicated to the development of oncology products that can improve the lives and outcomes of cancer patients. Recognizing that cancer is a complex disease involving changes to…

  • OncoSec Medical (ONCS) Presents at Rodman & Renshaw Conference

    Established in 2011, OncoSec Medical Incorporated (NASDAQ: ONCS) is a San Diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. Through its proprietary technology, the company means…

  • Onconova Therapeutics (ONTX) Presents at Rodman & Renshaw Conference

    Onconova Therapeutics, Inc. (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created an extensive library of…

  • Oculus Innovative Sciences (OCLS) Presents at Rodman & Renshaw Conference

    Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) has designed a humanitarian program to respond to unexpected disasters—floods, earthquakes, tsunamis, hurricanes, epidemics and even man-made calamities—by providing product (such as food or medical assistance) to these victims.…

  • Ocera Therapeutics (OCRX) Presents at Rodman & Renshaw Conference

    Ocera Therapeutics, Inc. (NASDAQ: OCRX) is a clinical stage biopharmaceutical companyfocused on the development and commercialization of proprietary compounds to treat acute and chronic orphan liver disease. Ocera’s lead program, OCR-002 (ornithine phenylacetate) is an…

  • Ocean Power Technologies (OPTT) Presents at Rodman & Renshaw Conference

    Ocean Power Technologies, Inc. (NASDAQ: OPTT) is a pioneer in renewable wave-energy technology that converts ocean wave energy into electricity. OPT’s proprietary PowerBuoy technology is based on a modular design and has undergone periodic ocean…

  • ENGlobal Corp. (ENG) Bolsters Management Team, Prepares for Market Growth

    Through its engineering and construction group, ENGlobal Corp. (NASDAQ: ENG) delivers innovative, cost-effective automation and specialty construction projects for customers around the world. Consistently included on Engineering News Record magazine’s annual list of the top…

  • Novatel Wireless (NVTL) Presents at Rodman & Renshaw Conference

    Novatel Wireless, Inc. (NASDAQ: NVTL) delivers intelligent wireless solutions that simplify the Internet of Things (IoT). The company has invented and reinvented ways in which the world stays connected and accesses information. With multiple first-to-market…

  • NovaBay Pharmaceuticals (NBY) Presents at Rodman & Renshaw Conference

    NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. NovaBay has two distinct product categories:…

  • Northwest Biotherapeutics (NWBO) Presents at Rodman & Renshaw Conference

    Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) is developing cancer vaccines designed to treat a broad range of solid tumor cancers more efficiently and cost-effectively than current treatments, and without the side effects of chemotherapy drugs. The…

  • Nivalis Therapeutics (NVLS) Presents at Rodman & Renshaw Conference

    Boulder, Colorado-based Nivalis Therapeutics, Inc. (NASDAQ: NVLS) is discovering solutions for cystic fibrosis. The company is developing a class of disease-modifying therapies designed to preserve intracellular GSNO (S-nitrosoglutathione), an endogenous molecule with cell-signaling effects that…

  • NeuroMetrix (NURO) Presents at Rodman & Renshaw Conference

    NeuroMetrix, Inc. (NASDAQ: NURO) is an innovative health-care company developing wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases and sleep disorders. Established in 1996 by Shai…

  • NephroGenex (NRX) Presents at Rodman & Renshaw Conference

    NephroGenex, Inc. (NASDAQ: NRX) is an innovator in the development of drugs to treat kidney disease with a first indication in diabetic nephropathy. It has been pioneering the development of PYRIDORIN (pyridoxaminedihydrochloride), a late stage…

  • NanoViricides (NNVC) Presents at Rodman & Renshaw Conference

    NanoViricides, Inc. (NYSE: NNVC) is a development stage company with a unique nanomedicine technology. The company is developing nanotechnology-based biomimetic anti-viral medicines called “nanoviricides.” So far, virus-specific nanoviricide drug candidates against five commercially important viral…

  • Nano Dimension (NNDMY) Presents at Rodman & Renshaw Conference

    Nano Dimension (OTC: NNDMY) was founded in 2012 and focuses on the research and development of advanced 3D electronics printing, including a printer for printing PCBs (printed circuit boards), and the development of nanotechnology- based…

  • Cleveland BioLabs (CBLI) Presents at Rodman & Renshaw Conference

    Cleveland BioLabs, Inc. (NASDAQ: CBLI), an innovative biopharmaceutical company, is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of toll-like immune receptor activators has applications in radiation…

  • MicroVision (MVIS) Presents at Rodman & Renshaw Conference

    MicroVision, Inc. (NASDAQ: MVIS) is a world leader in the innovation of a new generation of display technology. The company opens up a world of possibilities by bringing enhanced visibility to the world of mobility.…

  • Merus Labs International (MSLI) Presents at Rodman & Renshaw Conference

    Merus Labs International, Inc. (NASDAQ: MSLI) is on a quest to become a leading specialty pharmaceutical company with a diverse line of products in key global markets, with special geographic focus on North America and…

  • Medovex (MDVX) Presents at Rodman & Renshaw Conference

    Medovex Corporation (NASDAQ: MDVX) is a company dedicated to its mission of “better living through better medicine.” The highly successful and experienced healthcare executives at Medovex have a proven track record of building successful medical…

  • MDxHealth SA (MXDH) Presents at Rodman & Renshaw Conference

    MDxHealth SA (OTCBB: MXDH) is a multinational healthcare company that provides actionable epigenetic information to personalize the diagnosis and treatment of cancer.  The increased adoption of the company’s ConfirmMDx for Prostate Cancer testing solution within…

  • McEwen Mining (MUX) Presents at Rodman & Renshaw Conference

    McEwen Mining, Inc. (NYSE: MUX) is a growing gold and silver producer in the Americas. The company’s goal is to qualify for inclusion in the S&P 500. McEwen Mining’s principal assets include the following: interest…

  • MatinasBioPharma Holdings (MTNB) Presents at Rodman & Renshaw Conference

    MatinasBioPharma Holdings, Inc. (OTCQB: MTNB) is a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective antifungal and anti-bacterial therapeutics for the treatment of serious and life-threatening infections. The company’s lead anti-infective product…

  • MagneGas (MNGA) Presents at Rodman & Renshaw Conference

    Tampa-based MagneGas Corporation (NASDAQ: MNGA) is a technology company that counts a patented process that converts liquid waste into hydrogen based fuels among its inventions. The company sells MagneGas into the metal working market as…

  • Liquidmetal Technologies (LQMT) Presents at Rodman & Renshaw Conference

    Liquidmetal Technologies, Inc. (OTCBB: LQMT) is a leading force in the research, development and commercialization of amorphous metals. The company’s revolutionary class of patented alloys and processes form the basis of high performance materials in…

  • LabStyle Innovations (DRIO) Presents at Rodman & Renshaw Conference

    LabStyle Innovations Corp. (OTC: DRIO) develops and commercializes patented technology providing consumers with laboratory-testing capabilities using smart mobile devices. LabStyle’s flagship product is the Dario™ Diabetes Management Solution. Dario™ empowers people with diabetes to take…

  • La Jolla Pharmaceutical Company (LJPC) Presents at Rodman & Renshaw Conference

    La Jolla Pharmaceutical Company (NASDAQ: LJPC) is focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The company has several product candidates in…

  • Kamada (KMDA) Presents at Rodman & Renshaw Conference

    KamadaLtd. (NASDAQ: KMDA) is focused on plasma-derived protein therapeutics for orphan indications, and has a commercial product portfolio and a robust late-stage product pipeline. The company uses its proprietary platform technology and know-how for the…

  • Just Energy Group (JE) Presents at Rodman & Renshaw Conference

    Just Energy Group, Inc. (NYSE: JE) is an energy management solutions provider specializing in electricity, natural gas, solar and green energy. With offices located across the United States, Canada, and the United Kingdom, Just Energy…

  • iPass (IPAS) Presents at Rodman & Renshaw Conference

    iPass, Inc. (NASDAQ: IPAS) is a global Wi-Fi roaming market leader for enterprise employees and service provider subscribers. The company knits the world’s commercial Wi-Fi networks together to create a single global Wi-Fi network. With…

  • InVivo Therapeutics Holdings (NVIV) Presents at Rodman & Renshaw Conference

    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is on a quest to redefine the life of the spinal cord injury patient. Armed with cutting-edge technology and MIT science, experienced business and medical professionals at InVivo Therapeutics…

  • Inventergy Global (INVT) Presents at Rodman & Renshaw Conference

    Inventergy Global, Inc. (NASDAQ: INVT) is the brainchild of one of the intellectual property world’s most influential leaders, Joe Beyers. Having led global licensing for Hewlett-Packard for years, Beyers knew first-hand the challenges of leveraging…

  • Inuvo (INUV) Presents at Rodman & Renshaw Conference

    Inuvo, Inc. (NYSE: INUV) is an Internet marketing and technology company that delivers purchase-ready customers to advertisers through a broad network of desktop and mobile websites and app. The company has the opportunity to work…

  • International Stem Cell (ISCO) Presents at Rodman & Renshaw Conference

    International Stem Cell Corporation (OTCQB: ISCO) is a Montreal-based company devoted to developing its novel and innovative proprietary technologies for enhanced drug delivery. Through its cutting edge formulation platforms, the company has developed a broad…

  • IntelGenx (IGXT) Presents at Rodman & Renshaw Conference

    IntelGenx (OTC: IGXT) is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. The company’s unique multiple layer delivery system provides zero-order release of…

  • InspireMD (NSPR) Presents at Rodman & Renshaw Conference

    InspireMD, Inc. (NYSE: NSPR) was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio…

  • Inovio Pharmaceuticals (INO) Presents at Rodman & Renshaw Conference

    Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is on a quest to expand immune system stimulation to revolutionize the fight against cancers and infectious diseases. Stimulating the body’s immune system remains one of the most promising approaches…